, Volume 88, Issue 1, pp 1–11 | Cite as

Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788

  • Sandra E. File
  • Sharon Pellow
Review Article


The imidazodiazepine Ro 15-1788 is a benzodiazepine receptor antagonist that was initially reported to be lacking in intrinsic activity in a variety of test situations in which benzodiazepine-like effects can be identified. However, many recent studies have shown that this compound does indeed have intrinsic activity in a variety of behavioural, neurological, electrophysiological and biochemical preparations in both animals and man. The purpose of the present review is firstly to describe these intrinsic actions, and secondly to consider to what extent these intrinsic actions of Ro 15-1788 have implications for current concepts of the functioning of the benzodiazepine receptor.

Key words

Ro 15-1788 Benzodiazepine antagonist Behaviour Electrophysiology Biochemistry Neurology 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albertson TE, Bowyer JF, Paule MG (1982) Modification of the anticonvulsant efficacy of diazepam by Ro 15-1788 in the kindled amygdaloid seizure model. Life Sci 31:1597–1601Google Scholar
  2. Allikmets H, Rago LK (1983) The action of benzodiazepine antagonist Ro 15-1788 on the effects of GABA-ergic drugs. Naunyn-Schmeideberg's Arch Pharmacol 324:235–237Google Scholar
  3. Ator NA, Griffiths RR (1983) Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788. J Pharmacol Exp Ther 226:776–782Google Scholar
  4. Audi EA, Graeff FG (1984) Benzodiazepine receptors in the periaqueductal grey mediate anti-aversive drug action. Eur J Pharmacol 103:279–285Google Scholar
  5. Bennett DA, Corradi CL, Wilson DE (1984) The benzodiazepine antagonists, Ro 15-1788 and CGS 8216 differ in their interoceptive discriminative stimuli. Neurosci Abstr 10:260Google Scholar
  6. Biggio G (1984) Foot shock-induced decrease of low affinity GABA receptors: antagonism by Ro 15-1788. Communication given at the IUPHAR Congress, London, July 1984Google Scholar
  7. Bizzi A, Ricci MR, Veneroni E, Amato M, Garattini S (1984) Benzodiazepine receptor antagonists reverse the effects of diazepam on plasma corticosterone in stressed rats. J Pharm Pharmacol 36:134–135Google Scholar
  8. Bonetti EP, Pieri L, Cumin R, Schaffner R, Pieri M, Gamzu ER, Muller RKM, Haefely W (1982) Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology 78:8–18Google Scholar
  9. Borea PA, Supavilai P, Karobath M (1983) Differential modulation of etazolate or pentobarbital enhanced [3H]muscimol binding by benzodiazepine agonists and inverse agonists. Brain Res 280:383–386Google Scholar
  10. Braestrup C, Nielsen M, Honore T, Jensen LH, Petersen EN (1983) Benzodiazepine receptor ligands with positive and negative efficacy. Neuropharmacology 22:1451–1457Google Scholar
  11. Braestrup C, Nielsen M, Olsen CE (1980) Urinary and brain β-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc Natl Acad Sci USA 77:2288–2292Google Scholar
  12. Braestrup C, Schmiechen R, Neef G, Nielsen M, Petersen EN (1982) Interaction of convulsive ligands with benzodiazepine receptors. Science 216:1241–1243Google Scholar
  13. Brown CL, Martin IL (1983) Photoaffinity labelling of the benzodiazepine receptor cannot be used to predict ligand efficacy. Neurosci Lett 35:37–40Google Scholar
  14. Brown CL, Martin IL (1984a) Kinetics of [3H]Ro 15-1788 binding to membrain-bound rat brain benzodiazepine receptors. J Neurochem 42:918–923Google Scholar
  15. Brown CL, Martin IL (1984b) Photoaffinity labelling of the benzodiazepine receptor compromises the recognition site but not its effector mechanism. J Neurochem 43:272–273Google Scholar
  16. Chiu TH, Rosenberg HC (1982) Comparison of kinetics of [3H]-diazepam and [3H]-flunitrazepam binding to cortical synaptosomal membranes. J Neurochem 39:1716–1725Google Scholar
  17. Chiu TH, Rosenberg HC (1983) Conformational changes in benzodiazepine receptors induced by the antagonist Ro 15-1788. Mol Pharmacol 23:289–294Google Scholar
  18. Chopin P, Pellow S, File SE (1985) The effects of yohimbine on exploratory and locomotor behaviour are attributable to its effects at noradrenaline and not at benzodiazepine receptors. Neuropharmacology (in press)Google Scholar
  19. Cooper SJ (1982) Specific benzodiazepine antagonist Ro 15-1788 and thirst-induced drinking in the rat. Neuropharmacology 21:483–486Google Scholar
  20. Cooper SJ, Estall L (1985a) Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors. Neurosci Biobehav Rev 9:5–20Google Scholar
  21. Cooper SJ, Estall L (1985b) Intrinsic actions of Ro 15-1788 and CGS 8216: hyperphagia and anorexia induced in non-deprived rats consuming a palatable diet. Br J Pharmacol 84:96PGoogle Scholar
  22. Corda MG, Blaker WD, Mendelson WB, Guidotti A, Costa E (1983) β-Carbolines enhance shock-induced suppression of drinking in rats. Proc Natl Acad Sci USA 80:2072–2076Google Scholar
  23. Corda MG, Costa E, Guidotti A (1982) Specific proconvulsant action of an imidazobenzodiazepine (Ro 15-1788) on isoniazid convulsions. Neuropharmacology 21:91–94Google Scholar
  24. Crawley JN, Skolnick P, Paul SM (1984) Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse. Neuropharmacology 23:531–537Google Scholar
  25. Dantzer R, Perio A (1982) Behavioural evidence for partial agonist properties of Ro 15-1788, a benzodiazepine receptor antagonist. Eur J Pharmacol 81:655–658Google Scholar
  26. Darragh A, Lambe I, O'Boyle C, Kenny M, Brick I (1983) Absence of the central effects in man of the benzodiazepine antagonist Ro 15-1788. Psychopharmacology 80:192–195Google Scholar
  27. Duka TH, Ackenheil M, Dorow R, Noderer J, Welter D, Doenicke A (1984) Precipitated withdrawal by the benzodiazepine antagonist Ro 15-1788 with noradrenaline plasma levels. Communication presented at the CINP Congress, Florence, June 1984Google Scholar
  28. Emrich HM, Sonderegger P, Mai N (1984) Action of the benzodiazepine antagonist Ro 15-1788 in humans after sleep withdrawal. Neurosci Lett 47:369–373Google Scholar
  29. File SE (1982) The rat corticosterone response: habituation and modification by chlordiazepoxide. Physiol Behav 29:91–95Google Scholar
  30. File SE (1983) Proconvulsant action of CGS 8216. Neurosci Lett 35:317–320Google Scholar
  31. File SE (1984a) Modification of the seizures elicited by the benzodiazepine Ro 5-3663 — a comparison with picrotoxin. J Pharm Pharmacol 36:837–840Google Scholar
  32. File SE (1984b) Behavioural effects of pentylenetetrazole reversed by chlordiazepoxide and enhanced by Ro 15-1788. Naunyn-Schmiedeberg's Arch Pharmacol 326:129–131Google Scholar
  33. File SE (1984c) Behavioural pharmacology of benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry 8:19–31Google Scholar
  34. File SE, Green AR, Nutt DJ, Vincent ND (1984) On the convulsant action of Ro 5-4864 and the existence of a micromolar benzodiazepine binding site in rat brain. Psychopharmacology 82:199–202Google Scholar
  35. File SE, Hyde JRG (1979) A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. Pharmacol Biochem Behav 11:65–69Google Scholar
  36. File SE, Lister RG (1983) Interactions of ethyl-β-carboline-3-carboxylate and Ro 15-1788 with CGS 8216 in an animal model of anxiety. Neurosci Lett 39:91–94Google Scholar
  37. File SE, Lister RG, Nutt DJ (1982a) The anxiogenic action of benzodiazepine antagonists Neuropharmacology 21:1033–1037Google Scholar
  38. File SE, Lister RG, Nutt DJ (1982b) Intrinsic actions of benzodiazepine antagonists. Neurosci Lett 32:165–168Google Scholar
  39. File SE, Pellow S (1984a) The anxiogenic action of FG 7142 in the social interaction test is reversed by chlordiazepoxide and Ro 15-1788 but not by CGS 8216. Arch Int Pharmacodyn Ther 271:198–205Google Scholar
  40. File SE, Pellow S (1984b) The anxiogenic action of Ro 15-1788 is reversed by chronic, but not acute, treatment with chlordiazepoxide. Brain Res 310:154–156Google Scholar
  41. File SE, Pellow S (1985a) The benzodiazepine receptor antagonist Ro 15-1788 has an anxiogenic action in four animal tests of anxiety. Br J Pharmacol 84:103PGoogle Scholar
  42. File SE, Pellow S (1985b) No cross-tolerance between the stimulatory and depressant effects of benzodiazepines in mice. Behav Brain Res (in press)Google Scholar
  43. File SE, Pellow S (1986) Do the intrinsic actions of benzodiazepine receptor antagonists imply the existence of an endogenous ligand for benzodiazepine receptors? In: Biggio G, Costa E (eds) Advances in biochemical psychopharmacology: GABAergic transmission and anxiety. Raven Press, New York (in press)Google Scholar
  44. Gardner CR (1984) Inverse agonism of ethyl β-carboline on cerebellar purkinje cells. Communication presented to the CINP Congress, Florence, June 1984Google Scholar
  45. Gerhardt S, Liebman JM (1985) Self-regulation of ICSS duration: effects of anxiogenic substances, benzodiazepine antagonists and antidepressants. Pharmacol Biochem Behav 22:71–76Google Scholar
  46. Gherezghiher T, Lal H (1982) Ro 15-1788 selectively reverses antagonism of pentylenetetrazol-induced discriminative stimuli by benzodiazepines but not by barbiturates. Life Sci 31:2955–2960Google Scholar
  47. Gray JA (1982) Multiple book review of the neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. Behav Brain Sci 5:469–534Google Scholar
  48. Grecksch G, de Carvalho LP, Venault P, Chapouthier G, Rossier J (1983) Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro 15-1788. Life Sci 32:2579–2584Google Scholar
  49. Herling S, Shannon HE (1982) Ro 15-1788 antagonises the discriminative effects of diazepam in rats but not similar effects of pentobarbital. Life Sci 31:2105–2112Google Scholar
  50. Herberg LJ, Williams SF (1983) Anti-conflict and depressant effects by GABA agonists and antagonists, benzodiazepines and non-GABAergic anticonvulsants on self-stimulation and locomotor activity. Pharmacol Biochem Behav 19:625–633Google Scholar
  51. Hoffman DK, Britton DR (1983) Anxiogenic-like properties of benzodiazepine antagonists. Neurosci Abstr 9:129Google Scholar
  52. Honore T, Nielsen M, Braestrup C (1984) Barbiturate shift as a tool for determination of efficacy of benzodiazepine-receptor ligands. Eur J Pharmacol 100:103–107Google Scholar
  53. Hunkeler W, Mohler H, Pieri L, Polc P, Bonetti EP, Cumin R, Schaffner R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 290:514–516Google Scholar
  54. Jensen LH, Petersen EN (1983) Bidirectional effects of benzodiazepine receptor ligands against picrotoxin- and pentylenetetrazol-induced seizures. J Neural Transm 58:183–191Google Scholar
  55. Jensen LH, Petersen EN, Braestup C (1983) Audiogenic seizures in DBA/2 mice discriminate sensitively between low efficacy benzodiazepine receptor agonists and inverse agonists. Life Sci 33:393–399Google Scholar
  56. Jensen LH, Petersen EN, Braestrup C, Honore T, Kehr W, Stephens DN, Schneider H, Seidelmann D, Schmiechen R (1984) Evaluation of the β-carboline ZK 93 426 as a benzodiazepine receptor antagonist. Psychopharmacology 83:249–256Google Scholar
  57. Kaijima M, Le Gal La Salle G, Rossier J (1983) The partial benzodiazepine agonist properties of Ro 15-1788 in pentylenetetrazol-induced seizures in cats. Eur J Pharmacol 93:113–115Google Scholar
  58. Kawasaki K, Kodama M, Matsushita A (1984) An imidazodiazepine derivative, Ro 15-1788, behaves as a weak partial agonist in the crossed extensor reflex. Eur J Pharmacol 102:147–150Google Scholar
  59. Kehr W, Stephens DN (1984) Further evidence that central benzodiazepine receptor ligands may exhibit anxiogenic properties. Br J Pharmacol 81:42PGoogle Scholar
  60. Krespan B, Springfield SA, Haas H, Geller HM (1984) Electrophysiological studies on benzodiazepine antagonists. Brain Res 295:265–274Google Scholar
  61. Lal H, Shearman GT (1982) Attenuation of chemically-induced anxiogenic stimuli as a novel method for evaluating anxiolytic drugs: a comparison of clobazam with other benzodiazepines. Drug Dev Res Suppl 1:127–134Google Scholar
  62. Laurian S, Gaillard JM, Le PK (1984a) Dose effects of the benzodiazepine antagonist Ro 15-1788 on the auditory evoked potentials. Communication presented to the CINP Congress, Florence, June 1984Google Scholar
  63. Laurian S, Gaillard JM, Le PK, Schopf J (1984b) Effects of a benzodiazepine antagonist on the diazepam-induced electrical brain activity modifications. Neuropsychobiology 11:55–58Google Scholar
  64. LeFur G, Guilloux F, Mitrani N, Mizoule J, Uzan A (1979) Relationships between plasma corticosteroids and benzodiazepines in stress. J Pharmacol Exp Ther 211:305–308Google Scholar
  65. Liljequist S, Engel JA (1984) Reversal of the anti-conflict action of valproate by various GABA and benzodiazepine antagonists. Life Sci 34:2525–2533Google Scholar
  66. Lister RG (1985) The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev 9:87–93Google Scholar
  67. Lister RG, Greenblatt DJ, Abernethy DR, File SE (1984) Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat. Brain Res 83:183–186Google Scholar
  68. Little HJ (1984) The effects of benzodiazepine agonists, inverse agonists and Ro 15-1788 on the responses of the superior cervical ganglion to GABA in vitro. Br J Pharmacol 83:57–68Google Scholar
  69. Mansbach RS, Stanley JA, Barrett JE (1984) Ro 15-1788 and β-CCE selectively eliminate diazepam-induced feeding in the rabbit. Pharmacol Biochem Behav 20:763–766Google Scholar
  70. Marescaux C, Micheletti G, Vergnes M, Depaulis A, Rumbach L, Warter J-M (1984) Biphasic effects of Ro 15-1788 on spontaneous petit mal-like seizures in rats. Eur J Pharmacol 102:355–359Google Scholar
  71. Medina JH, Novas ML, de Robertis E (1983) Chronic Ro 15-1788 treatment increases the number of benzodiazepine receptors in rat cerebral cortex and hippocampus. Eur J Pharmacol 90:125–128Google Scholar
  72. Mereu G, Fanni B, Serra M, Concas A, Biggio G (1983) β-carbolines activate neurones in the substantia nigra pars reticulata: an effect reversed by diazepam and Ro 15-1788. Eur J Pharmacol 96:129–132Google Scholar
  73. Mohler H (1982) Benzodiazepine receptors: differential interaction of benzodiazepine agonists and antagonists after photoaffinity labelling with flunitrazepam. Eur J Pharmacol 80:435–436Google Scholar
  74. Mohler H, Okada T (1977) Benzodiazepine receptors: demonstration in the CNS. Science 198:849–851Google Scholar
  75. Mohler H, Richards JG (1981) Agonist and antagonist benzodiazepine receptor interaction in vivo. Nature 294:763–765Google Scholar
  76. Morag M, Myslobodsky M (1982) Benzodiazepine antagonists abolish electrophysiological effects of sodium valproate in the rat. Life Sci 30:1671–1677Google Scholar
  77. Morgan PF, Lloyd HGE, Stone TW (1983) Benzodiazepine inhibition of adenosine uptake is not prevented by benzodiazepine antagonists. Eur J Pharmacol 87:121–126Google Scholar
  78. Mormede P, Dantzer R, Perio A (1984) Relationship of the effects of the benzodiazepine derivative clorazepate on corticosterone secretion with its behavioural actions. Antagonism by Ro 15-1788. Pharmacol Biochem Behav 21:839–843Google Scholar
  79. Nielsen EB, Jepsen SA, Nielsen M, Braestrup C (1984) DMCM discrimination: a drug cue that may involve set-point regulation for inverse agonist or BZ action at BZ receptors. Communication presented to CINP Congress, Florence, June 1984Google Scholar
  80. Nielsen EB, Valentine JD, Holohean AM, Appel JB (1983) Benzodiazepine receptor mediated discriminative cues: effects of GABAergic drugs and inverse agonists. Life Sci 33:2213–2220Google Scholar
  81. Nutt D (1983) Pharmacological and behavioural studies of benzodiazepine antagonists and contragonists. In: Biggio G, Costa E (eds) Benzodiazepine receptor site ligands: Biochemistry and pharmacology. Raven Press, New York, pp 153–174Google Scholar
  82. Nutt DJ, Cowen PJ, Little HJ (1982) Unusual interactions of benzodiazepine receptor antagonists. Nature 295:436–438Google Scholar
  83. Olsen RW (1982) Drug interactions at the GABA receptor-ionophore complex. Ann Rev Pharmacol Toxicol 22:245–277Google Scholar
  84. Ongini E (1983) Behavioral and EEG effects of benzodiazepines and their antagonists in the cat. In: Biggio G, Costa E (eds) Benzodiazepine receptor site ligands: Biochemistry and pharmacology. Raven Press, New York, pp 211–225Google Scholar
  85. Pellow S (1985) Can drug effects on anxiety and convulsions be separated? Neurosci Biobehav Rev 9:55–73Google Scholar
  86. Pellow S, Chopin P, File SE (1985) Are the anxiogenic effects of yohimbine in the social interaction test mediated at benzodiazepine receptors? Neurosci Lett 55:5–9Google Scholar
  87. Pellow S, File SE (1984) Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations. Psychopharmacology 83:304–315Google Scholar
  88. Pellow S, File SE (1985a) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a nouel test of anxiety in the rat. Pharmacol Biochem Behav (in press)Google Scholar
  89. Pellow S, File SE (1985b) The effects of putative anxiogenic compounds (FG 7142, CGS 8216 and Ro 15-1788) on the rat corticosterone response. Physiol Behav (in press)Google Scholar
  90. Pellow S, File SE, Herberg LJ (1984a) Intracranial self-stimulation distinguishes between two benzodiazepine antagonists. Neurosci Lett 47:173–177Google Scholar
  91. Pellow S, Herberg LJ, File SE (1984b) The effects of the β-carboline FG 7142 on intracranial self-stimulation in the rat. Pharmacol Biochem Behav 21:667–669Google Scholar
  92. Pieri L, Biry P (1985) Isoniazid-induced convulsions in rats: effects of Ro 15-1788 and β-CCE. Eur J Pharmacol (in press)Google Scholar
  93. Polc P, Bonetti EP, Schaffner R, Haefely W (1982) A three state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, β-carbolines, and phenobarbitone. Naunyn-Schmiedeberg's Arch Pharmacol 321:260–264Google Scholar
  94. Polc P, Laurent JP, Scherschlicht R, Haefely W (1981) Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788. Naunyn-Schmiedeberg's Arch Pharmacol 316:317–325Google Scholar
  95. Prado de Carvalho L, Greksch G, Chapouthier G, Rossier J (1983) Anxiogenic and non-anxiogenic benzodiazepine antagonists. Nature 301:64–66Google Scholar
  96. Pratt JA, Stolerman IP (1984) Chlordiazepoxide, Ro 15-1788 and conditioned taste aversion (CTA). Communication presented at the IUPHAR Congress, London, July 1984Google Scholar
  97. Robertson HA, Riives ML (1983) A benzodiazepine antagonist is an anticonvulsant in an animal model for limbic epilepsy. Brain Res 270:380–382Google Scholar
  98. Rodgers RJ, Waters AJ (1984) Effects of the benzodiazepine antagonist Ro 15-1788 on social and agonistic behaviour in male albino mice. Physiol Behav 33:401–409Google Scholar
  99. Rodgers RJ, Waters AJ (1985) Benzodiazepines and their antagonists: a pharmacoethological analysis with particular reference to effects on “aggression”. Neurosci Biobehav Rev 9:21–35Google Scholar
  100. Rodgers RJ, Waters AJ, Rosenfield S (1983) Evidence for intrinsic behavioural activity of the benzodiazepine antagonist, Ro 15-1788, in male mice. Pharmacol Biochem Behav 19:895–898Google Scholar
  101. Rosenberg HC, Chiu TH (1985) Blood pressure response to Ro 15-1788, a benzodiazepine antagonist. Life Sci 36:781–787Google Scholar
  102. Schechter MD (1984) Specific antagonism of the behavioural effects of chlordiazepoxide and pentobarbital in the rat. Prog Neuropsychopharmacol 8:359–364Google Scholar
  103. Schenberg LC, Graeff FG (1978) Role of the periaqueductal gray substance in the anti-anxiety action of the benzodiazepines. Pharmacol Biochem Behav 9:287–295Google Scholar
  104. Schopf J, Laurian S, Le PK, Gaillard J-M (1984) Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation. Pharmacopsychiatry 17:79–83Google Scholar
  105. Scollo-Lavizzari G (1984) The anticonvulsant effect of the benzodiazepine antagonist, Ro 15-1788: an EEG study in 4 cases. Eur Neurol 23:1–6Google Scholar
  106. Skerritt JH, MacDonald RL (1983) Benzodiazepine Ro 15-1788: electrophysiological evidence for partial agonist activity. Neurosci Lett 43:321–326Google Scholar
  107. Spirt NM, Zanko M, Bautz G, O'Brien (1982) Lack of benzodiazepine receptor alteration after acute or sub-chronic benzodiazepine antagonist (Ro 15-1788) administration in mice. Neurosci Abstr 8:375Google Scholar
  108. Squires RF, Braestrup C (1977) Benzodiazepine receptors in rat brain. Nature 266:732–734Google Scholar
  109. Supavilai P, Karobath M (1983) Differential modulation of [35S]TBPS binding by the occupancy of benzodiazepine receptors with its ligands. Eur J Pharmacol 91:145–146Google Scholar
  110. Tang M, Soroka S, Falk JL (1983) Agonistic action of a benzodiazepine antagonist: Effects of Ro 15-1788 and midazolam on hypertonic NaCl intake. Pharmacol Biochem Behav 18:953–955Google Scholar
  111. Taylor SC, Little HJ, Nutt DJ, Sellars N (1985) A benzodiazepine agonist and contragonist have hypothermic effects in rodents. Neuropharmacology 24:69–73Google Scholar
  112. Thiébot M-H, Childs M, Soubrié P, Simon P (1983) Diazepam-induced release of behaviour in an extinction procedure: its reversal by Ro 15-1788. Eur J Pharmacol 88:111–116Google Scholar
  113. Thomas JW, Tallman JF (1983) Photoaffinity labelling of benzodiazepine receptors causes altered agonist-antagonist interactions. J Neurosci 3:433–440Google Scholar
  114. Turkish S, Cooper SJ (1984) Enhancement of saline consumption by chlordiazepoxide in thirsty rats: antagonism by Ro 15-1788. Pharmacol Biochem Behav 20:869–873Google Scholar
  115. Valin A, Dodd RH, Liston DR, Potier P, Rossier J (1982) Methyl-β-carboline-induced convulsions are antagonised by Ro 15-1788 and by propyl-β-carboline. Eur J Pharmacol 85:93–97Google Scholar
  116. Vellucci SV, Webster RA (1982) Antagonism of the anticonflict effects of chlordiazepoxide by β-carboline carboxylic acid ethyl ester, Ro 15-1788 and ACTH (4–10). Psychopharmacology 78:256–260Google Scholar
  117. Vellucci SV, Webster RA (1984) Antagonism of caffeine-induced seizures in mice by Ro 15-1788. Eur J Pharmacol 97:289–293Google Scholar
  118. Vellucci SV, Webster RA (1983) Is Ro 15-1788 a partial agonist at benzodiazepine receptors? Eur J Pharmacol 90:263–268Google Scholar
  119. Wagner JA, Katz RJ (1984) Anxiogenic action of benzodiazepine antagonists Ro 15-1788 and CGS 8216 in the rat. Neurosci Lett 48:317–320Google Scholar
  120. Wauquier A, Ashton D (1985) The benzodiazepine antagonist, Ro 15-1788, increases REM and slow wave sleep in the dog. Brain Res 308:159–161Google Scholar
  121. Williams M, Risley EA (1982) Interaction of the benzodiazepine antagonists, CGS 8216 and Ro 15-1788, with central adenosine A-1 receptors. Arch Int Pharmacodyn 260:50–53Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • Sandra E. File
    • 1
  • Sharon Pellow
    • 1
  1. 1.MRC Neuropharmacology Research Group, Department of Pharmacology, The School of PharmacyUniversity of LondonLondonUK

Personalised recommendations